Posts with tag Marketing authorisation

This article is part of a series that covers the proposed reforms to EU pharmaceutical legislation. To view our first article and the whole series, please click here. As medicinal products are not permitted to be placed on a market until the marketing authorisation (“MA”) for that market is obtained, the procedural aspects of applying for and obtaining MAs are a material hurdle to obtaining market access and making products available to patients. As part of...